Beneficial ownership reporting

Beneficial ownership reporting obligations are landing on Healthcare & Life Sciences companies harder than most sectors acknowledge, largely because private equity ownership structures in hospital systems, specialty pharmacies, and lab networks create layered disclosure complexity that generic compliance programs miss. The U.S. Financial Crimes Enforcement Network's Corporate Transparency Act beneficial ownership rule, now in active enforcement posture, reaches many privately held healthcare entities that previously had no federal disclosure obligation of this type. State-level scrutiny is compounding this: the California Attorney General and New York Attorney General have both signaled heightened review of ownership transparency in healthcare transactions.